ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology Technology excellence validated by winning first place at 'Novo Nordisk Partnering Day Korea 2026' SEOUL, South Korea, April 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a...
Hence then, the article about immunoforge to accelerate cns drug development with innovative bbb shuttle platform lmt15 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15' )
Also on site :
- Water Bill Rate Hike Map: Where 300,000 Could Pay Hundreds More in Missouri
- The Evening News: Local Restaurant Owner Charged With Attempted Murder, UNC Faculty Committee Meeting
- A Nostalgic Childhood Fave Is Dropping a New Lineup of Functional Beverages